(84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
KH MA MD TN |
(30) |
Priority: |
18.07.2022 US 202263368722 P 18.07.2022 US 202263368724 P 18.07.2022 US 202263368726 P 18.07.2022 US 202263368728 P 18.07.2022 US 202263368730 P 18.07.2022 US 202263368731 P 18.07.2022 US 202263368734 P 18.07.2022 US 202263368735 P 18.07.2022 US 202263368736 P 18.07.2022 US 202263368737 P 18.07.2022 US 202263368738 P 18.07.2022 US 202263368741 P 18.07.2022 US 202263368742 P 18.07.2022 US 202263368744 P 07.04.2023 US 202318297346 10.04.2023 US 202363495198 P
|
(71) |
Applicant: Renagade Therapeutics Management Inc. |
|
Cambridge, Massachusetts 02139 (US) |
|
(72) |
Inventors: |
|
- GASIUNAS, Giedrius
10257 Vilnius (LT)
- LADHA, Alim
Cambridge, MA 02139 (US)
- PRESNYAK, Vladimir
Cambridge, MA 02139 (US)
- JAYARAMAN, Muthusamy
Cambridge, MA 02139 (US)
- NARAYANAN, Elisabeth
Watertown, MA 02472 (US)
|
(74) |
Representative: Atkins, James Gordon John et al |
|
Kilburn & Strode LLP
Lacon London
84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB) |
|